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ABSTRACT 
The production of cement is related to multi-stage processes that include quarrying, 
crushing, raw milling, blending and production of clinker and the final process of cement 
production is packaging. Cement workers are exposed to various kinds of occupational 
hazards, but the most hazardous exposure is dust. Several studies have revealed that the 
prevalence of respiratory symptoms is much higher among workers exposed to dust 
compared to workers who are not exposed to dust. This study was motivated by an 
encounter with several workers, especially from cement industries and construction 
companies, who presented with chronic respiratory symptoms during medical surveillance. 
Upon further investigation, it was revealed that they suffer from chronic respiratory disease. 
This study was conducted in Johannesburg, specifically in the Roodepoort and Booysens 
areas. This is because these areas are situated near mines or cement industries that 
manufacture either cement or ready-mix concrete. 
The main aim of this study was to assess the prevalence of chronic respiratory symptoms 
among workers exposed to cement dust. A cross-sectional study was conducted with 81 
workers from two cement production companies - 31 (38.27%) workers from Company 1 
and 50 (61.72%) workers from Company 2. Data was collected using a questionnaire 
(Annexure C) and lung function tests were used to supplement the findings. A majority of 
the participants in this study were male, i.e. 87% from Company 1 and 91% from Company 
2.  The study found that respiratory symptoms such as coughing, sneezing, wheezing, 
recurring blocked nose, bouts of coughing, chest tightness, phlegm, chest pain and 
breathlessness were significantly prevalent among participants from both companies. 
Workers who reported smoking at the time of data collection were 6.34 times more likely to 
experience respiratory symptoms.   
Based on the findings of this study, it was concluded that chronic respiratory symptoms are 
prevalent in cement-exposed workers in the Gauteng Province. It is recommended that 
engineering and housekeeping control measures - such as the use of High Efficiency 
Particulate Air (HEPA) vacuums to clean up dust instead of dry sweeping - be implemented. 
This control measure will help in reducing silica exposure during production. Workers 
should also be encouraged to use respiratory protection gear during working hours when 
they are exposed to dust. Furthermore, chest x-rays and blood tests should be used to 
 
 
vii 
 
identify the kinds of chemicals that workers are exposed to. This can be very useful in terms 
of detecting health problems earlier. 
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CHAPTER 1 
INTRODUCTION 
This chapter provides a background to the study, focuses on the research problem, and 
discusses similar previous studies that have been conducted globally. The aims and 
objectives of the study are also discussed in this chapter, as well as the relevance of the 
study. 
1.1 Background to the study 
In developing countries, millions of people work in dusty environments on a daily basis, and 
this includes cement industry workers. There are a number of dust-related studies that have 
been conducted globally in portland cement production plants (Ballal et al., 2004). Workers 
in raw material departments may be exposed to the raw materials used in cement 
production (such as limestone, chalk, clay and shale), to clinker, as well as to portland 
cement dust. One of the major illnesses in cement industries is occupational lung disease, 
which is usually exacerbated by long-term exposure to toxic and irritating substances 
(Akanbi et al., 2014). 
The production of cement is based on multiple stage processes that involve the following 
stages: quarrying, crushing, raw milling, blending and production of clinker, milling and the 
final process of cement packaging. It involves raw materials being dried, ground, 
proportioned and homogenized before they can be transferred to rotary kilns to form clinker, 
which is then crushed into smaller particles at the cement grinding mill to make ordinary 
portland cement; or  mixed with other products to make other types of cement (Hassan, 
2005). Cement dust is generated from all these cement-making processes – including 
quarrying, crushing, calcining, grinding, blending, packaging, as well as transportation of 
the final product (Zeleke et al., 2011). The amount of cement dust varies between different 
stages of cement production (Zeleke et al., 2011). Dust exposure levels also depend on the 
production rate, production technology or the machines being used, and the availability and 
efficiency of dust engineering control measures (Ashford, 1993). 
The main aim of this study is to assess the prevalence of chronic respiratory symptoms 
among workers exposed to cement dust. A key reason for conducting this study is that no 
study of this nature has ever been conducted in the Johannesburg area to the best of the 
researcher’s knowledge. This study was conducted in Johannesburg, specifically in the 
areas of Roodepoort and Booysens, because these areas are situated near mines or 
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cement industries that manufacture either cement or ready-mix concrete. 
1.2 Research problem 
Despite certain exposure limits on the emission of air pollutants in the atmosphere that have 
been put in place, the number of people who die each year due to complications from 
respiratory disease has continued to rise (Lage et al., 2016). Air pollution has been reported 
to be the most common factor that contributes to the increased morbidity rates of respiratory 
diseases, cardiovascular infections, lung cancer and issues  that contribute to other 
diseases, such as  chronic diabetes (Lage et al., 2016). 
The notion that air pollution is hazardous to human health has been researched extensively 
and is well-documented. The World Health Organisation estimates that, globally, at least 
two million people die every year prematurely due to health problems – mostly from 
respiratory problems associated with a lack of clean air. Air free from chemicals or dust 
particles is a basic necessity and a right for human life, but the quality of air continues to 
deteriorate as it is polluted by various pollutants. Almost all the cement processing units of 
a cement factory (e.g. raw mill, kiln, coal mill and the cement mill) produce air pollution. 
Activities involved in post-manufacturing processes - like open-air handling, loading and 
unloading - contribute to dust particles being leaked into the environment. These are known 
as fugitive sources of emissions (Mehraj and Bhat, 2013). 
Chronic exposure to portland cement dust is associated with a greater prevalence of various 
kinds of clinical conditions, including both respiratory and non-respiratory illnesses. The 
intensity of both these health conditions depends on the level of exposure,  and therefore 
the use of personal protective equipment is recommended to protect workers from adverse 
health effects (Manjula et al., 2013). 
There are regulatory measures that are put in place, known as occupational exposure limits 
(OELs), to control exposure to workplace stressors. These measures are intended to 
protect the worker’s health for 8 hours a day and 5 days a week for about 40 years 
(Occupational Health and Safety Act, 1993). In a respiratory system, inhalation is 
considered a route of exposure. Long-term exposure is usually 8 hours, while short-term 
exposure is approximately 15 minutes (WHO, 2000). There are loopholes in the legislation 
governing OELs, as exposure levels are not applicable to environmental exposure where 
more susceptible groups such as the elderly, children and pregnant women live. Instead, 
these limits are based on the exposure levels of healthy adult males. Other factors such as 
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workers infected with HIV or tuberculosis, females, hyper-sensitive workers, smokers and 
Caucasians have not been considered. OELs are also based on an exposure of 8 hours, 
while some workers work 12 hours a day. Furthermore, OELs for silica were last updated 
24 years ago (WHO, 2000). 
1.3  Previous studies 
Early studies on the unfavourable respiratory impacts of cement dust exposure incorporate 
both non-positive studies, and studies that associate cement production work with chronic 
airway inflammation and decreases in dynamic lung volumes (Fell and Nordby, 2017). Other 
studies indicate a reduced forced vital capacity (FVC) or forced expiratory volume in one 
second (FEV1), and a higher prevalence of chronic respiratory symptoms and chronic 
obstructive pulmonary disease (COPD) in cement production workers (Mirzaee et al., 2008). 
Several studies of lung function in cement production workers reported no significant results 
(Thepaksorn et al., 2013). Thus, existing literature is conflicting and conclusions about 
exposure response relationships or safe levels of exposure cannot be drawn (Nordby et al., 
2011). 
According to Peters et al. (2009) in a study that was conducted in the Netherlands, inhalable 
dust concentrations at the construction site that was under investigation ranged from 0.05 
mg/m³ to 34 mg/m³, with a geometric mean (GM) concentration of 1.0 mg/m³. For inhalable 
cement dust, the GM concentration was 0.3 mg/m³ (range 0.02–17 mg/m³). The most 
significant levels of inhalable dust concentration were reported among solid repairers and 
tile setters, while fortification and pouring specialists demonstrated the lowest levels of 
inhalable dust. The most elevated levels were seen in cement production, especially during 
cleaning tasks (Peters et al., 2009). 
1.4  Aims, objectives and relevance of the study 
1.4.1  Aim of the study 
This study aims to investigate the prevalence of chronic respiratory diseases in workers 
exposed to cement dust in cement dust manufacturing or production industries by analysing 
lung capacity and airway clinical manifestations among workers in various occupations, and 
at various degrees of exposure to thoracic dust. 
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1.4.2  The specific objectives 
Three objectives were identified for the study and are discussed below. 
Objective 1 
To examine and characterize the health effects that cement dust exposure has on the 
human respiratory system. 
Method utilised to achieve Objective 1 
This objective was achieved by conducting lung function tests (spirometry) on workers. 
 
Objective 2 
To explore factors contributing to respiratory symptoms. 
 
Method utilised to achieve Objective 2 
This was achieved by using a questionnaire that workers completed to explore factors 
contributing to respiratory symptoms.  
 
Objective 3 
To evaluate worker practices concerning the use of respiratory protection gear. 
 Method utilised to achieve Objective 3 
This objective was achieved by using a questionnaire. Workers answered questions 
regarding their respiratory protection gear and a walk-through was conducted at the 
facilities to observe worker practices concerning the use of respiratory protection gear. 
 
1.4.3 Relevance of the study  
This study will help with identifying the number of individuals who experience respiratory 
side-effects among cement dust exposed workers in the designated cement and concrete 
businesses in the Gauteng region, as well as establish how prevalent chronic respiratory 
 
 
5 
 
symptoms are among the identified study participants. The study will likewise aid in the 
advancement of new strategies and the development of new policies on air pollution - 
specifically on cement dust exposure, air quality and preventative measures that can 
substantially improve or reduce respiratory symptoms that can eventually lead to 
respiratory diseases. The outcomes of this study will also help to improve health systems 
and reduce the number of people who are being treated and call in sick due to respiratory 
symptoms. If more people are informed about cement dust exposure and its effects on the 
respiratory system, they will take better precautions and use the Personal Protective 
Equipment (PPE) provided for respiratory protection appropriately, i.e. put a respiratory 
mask over their mouth and nose for protecting against cement dust. The results of this 
study will contribute to existing literature in this field of research and will educate others on 
the effects of cement dust on the respiratory system. It will also stimulate further research. 
In Chapter 2, an in-depth literature review on the cement industry, occupational exposure 
limits, legislation and previous studies from around the world will be presented.  
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
LITERATURE REVIEW 
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In this chapter, studies related to cement dust exposure, the prevalence of respiratory 
symptoms among workers and studies related to the imperil presence of cement dust and 
the pervasiveness of respiratory symptoms among workers will be discussed 
 
2.1 The Cement Industry 
 
Cement is one of the most imperative building materials used in the world, particularly in 
South Africa. Cement demand is cyclical and reliant on strong economic growth, and 
despite the weak economic outlook in South Africa, there are some positive early signs that 
the cement industry can be salvaged (Brown and Hasson, 2016). According to 
Rafeemanesh et al. (2015), more than 250 000 people in Iran are employed in concrete 
manufacturing industries. Workers in cement mills are exposed to dust during several 
stages of manufacturing and production, including excavating and handling raw materials, 
grinding clinker, blending, packing and distributing the finished products (Rafeemanesh et 
al., 2015). 
The materials required to produce cement products are mainly extracted from open cast 
mines. The production of cement takes place in multiple stages: The first stage involves the 
extraction of limestone, aluminium oxide, clay, silica and chromium. The second stage 
entails the crushing, separating and storing of materials. Furthermore, the ingredients are 
quantified to produce an accurate mixture and get calcinated in kilns at approximately 1500 
°C, producing a final product, which is the pre-cement called clinker. This final product is 
crushed, mixed with plaster and then packed into sacks (Portland, 2015). The key products 
obtained from this process are: portland cement puzzolanic, which is resistant to chemical 
agents such as saline waters and salty soils; ordinary Portland cement, which is used for 
high mechanical strength; and portland cement with granulated blast furnace slag, mainly 
used in driving works sewage, marine works and salty media (Portland, 2015). 
Ready-mix concrete (RMC) is a ready-to-use material, with a pre-determined mixture of 
cement, sand, aggregates and water. RMC is a type of concrete that is manufactured in a 
factory as per the specifications of the customer, usually at a centrally located batching 
plant. Most ready mixed concrete is currently manufactured under computer-controlled 
operations, transported and placed at project sites using different equipment and methods. 
It is often delivered to work sites using truck mixers capable of mixing the ingredients of the 
concrete en-route or just before the batch is delivered. The use of  RMC is facilitated through 
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a truck-mounted boom placer that can pump the product for ready use at multi-storied 
construction sites (Shah, 2014). 
2.2 The health effects of cement dust exposure and its mode of transmission 
Portland cement is made up of calcium oxide, dicalcium silicate, silicon dioxide, ferric oxide, 
magnesium oxide, selenium, aluminium trioxide, thallium, and contains a low concentration 
of hexavalent chromium (Aminian et al., 2013). In cement industries, workers are exposed 
to various health hazards during the making and handling of cement. These hazards include 
silica dust, high temperatures, as well as noise. Nevertheless, the main occupational threat 
in the cement production industry is respirable dust particles, which are  emitted at most 
stages of the production into the environment, with higher concentrations found in the crane, 
packaging and crusher sectors (Aminian et al., 2013). The main modes of exposure to 
respirable dust are dermal, inhalation and unintended ingestion (Sundararaj, 2012). There 
is substantial evidence that workers in the cement industry are at increased risk of 
respiratory symptoms and often, obstructive airway disease has been the issue under 
investigation. 
Dust is produced and discharged into the atmosphere through diverse production 
processes (Kakooei et al., 2012). Several epidemiological studies have shown an amplified 
incidence of respiratory tract impairment among cement production workers and potential 
conflicting effects on the respiratory system. Portland cement dust is thought to have the 
potential to induce malignant diseases in the lungs and associated areas, such as 
respiratory cancer and laryngeal cancer (Kakooei et al., 2012). The concentration of 
airborne cement dust varies significantly in varying manufacturing operations, and workers 
who work in the dusty cement production process - such as crushers or raw mill workers - 
have higher occupational exposure to total and respirable dust (Poornajaf et al., 2010). 
Cement contains various types of chemicals, including silicon, aluminium, calcium and iron. 
In addition to silica and lime together,  the exposure to such chemicals can cause 
synergistic exposure effects (Rahmani et al., 2018). The most prevalent exposure effects 
among cement workers are allergies and complications related to the respiratory system. 
Rahmani et al. (2018) suggest that long-term cement dust exposure could cause epithelial 
tissue damage. Cement dust exposure can also cause chronic obstructive pulmonary 
disease (COPD). However, the most important potentiating factors are smoking, 
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occupational exposure to fumes, chemicals, genetic susceptibility, as well as industrial air 
pollution (HSE, 2017). 
2.3 Cement dust exposure, a world-wide problem 
Chronic obstructive pulmonary disease (COPD) due to all causes, predominantly smoking, 
accounts for a significant number of deaths in Great Britain. Over the last 10 years there 
were, on average, 28 000 deaths per year in total with COPD recorded as the underlying 
cause of death (HSE, 2017). It is difficult to estimate the prevalence of COPD due to the 
nature of the disease and misdiagnosis (HSE, 2017). According to recent research 
conducted in 2010, the Health Survey for England projected that approximately 6% of adults 
have probable airflow limitation consistent with COPD, equivalent to around 3 million cases 
in Great Britain currently (HSE, 2017). The classic diseases of “dusty” occupations may be 
on the decline; however, this does not mean that they no longer exist. Environmental risk 
factors account for approximately a third of the world’s disease burden, according to the 
World Health Organization (WHO, 2005). Dust airborne particles settle in the lungs and 
cause mucus hyper-secretion, lung function impairment, lung irritation, chronic obstructive 
disease, lung inflammation, respiratory disease and restrictive lung disease (Sivaharini et 
al., 2018). Occupational lung diseases typically take longer to manifest and have a long 
latency period; therefore, current deaths reflect the effects of past working conditions (HSE, 
2017).  
Although personal protective clothing should be worn at all times in a work-place, studies 
from third world countries show that some industries seldom provide precautionary 
measures (Merenu et al., 2007). The severity of respiratory function impairment has been 
shown to be the  result of years of exposure (Merenu et al., 2007). However, there are other 
studies that contradict this statement (Fell et al., 2003). Another study that was conducted 
in Denmark in 1990 suggested that long-term exposure to cement dust does not lead to 
higher morbidity rates compared to other types of construction work (Vesbo and 
Rasmussen, 1990). 
2.4 Previous studies on the health effects of cement dust exposure among 
workers and its outcomes 
Communities in developing countries face higher risks of developing respiratory diseases 
because of the production of dust and smoke in different industrial and occupational 
sectors. The biological responses exerted by the particles influence the health risks posed 
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by inhaled dust particles (Rebello et al., 2014). Studies have reported associations between 
chronic respiratory symptoms and/or chronic obstructive pulmonary diseases and cement 
dust exposure (Tungu et al., 2013). The mechanism of adverse  dust exposure on the 
respiratory systems of  cement factory workers is uncertain (Tungu et al., 2013). 
Environmental working conditions in construction areas, notably exposure to organic and 
mineral dusts, have been associated with induced respiratory diseases. A study among 
workers at a cement factory in Norway  suggested that airway inflammation was caused by 
an increased percentage of neutrophils in induced sputum after dust exposure (Tungu et 
al., 2013). Another study on dust exposure and respiratory symptoms among cement factory 
workers done in the United Arab Emirates  revealed that the highest occupational exposure 
to dust occurred in the packaging and raw mill areas of the cement industry (Ahmed and 
Abdullah, 2012). 
Substantial evidence suggests that workers in the cement industry face a higher risk of 
respiratory symptoms. Most often, obstructive airway diseases are the main issues being 
investigated. The association between exposure to cement dust and lung function 
impairment has been found to be contradictory (Sundararaj, 2012). This is also true   for 
the association between respiratory tract malignancies and exposure to cement dust, 
particularly lung and larynx cancer (Sundararaj, 2012). Several researchers have reported 
that chronic occupational exposure to dust in cement factories leads to a higher prevalence 
of chronic respiratory symptoms such as sputum, coughing, the altering of pulmonary 
functions, wheezing and dyspnoea.  However, researchers such as Ahmed and Abdullah 
(2012) have reported that the differences between exposed and unexposed workers for most 
respiratory symptoms are insignificant. The effects caused by pollution on a human body 
depend on the agent, the intensity and the location where aggression occurs. Effects of 
pollutants on the respiratory system can appear on the upper respiratory tract or the lower 
respiratory tract in an acute phase and can develop into a chronic condition as time goes 
by (Lage et al., 2013). The most important group of occupational diseases in the cement 
industry are respiratory tract disorders, and these are the result of inhaling airborne dust. 
Often associated with emphysema, chronic bronchitis has been reported as the most 
prevalent respiratory disease (Neghab and Choobineh, 2007). 
Atmospheric dust contributes significantly to air pollution, especially in dry climates 
(Branquinho et al., 2008). Mineral dust consists of high concentrations of various metals 
known to have toxic effects not only in animals and plants, but also in humans, i.e. the 
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fraction of particles with a size below 5 micrometres. A proportionate mortality study on 
cement workers was conducted in 2012 in Greece, and the study found that production 
workers in the cement industry presented with a higher respiratory and lung cancer mortality 
rate, and these findings cannot be solely attributed to the confounding effect of smoking 
(Rachiotis et al., 2012). Further research, including the use of prospective cohort studies, 
is needed to determine the link between the two confounding factors (Rachiotis et al., 2012). 
A study on decreased airflow and the prevalence of chronic bronchitis amongst cement 
workers in South Africa revealed different significant outcomes in relation to duration of 
exposure to cement dust and degree of adverse effects (Acutt, 2004). Airflow restriction 
was evident in 9 (n = 138; 6,52%) spirograms, with the respondents all showing a mild 
degree of limitation. The mean cumulative exposure intensity (CEI) was 25,44, within a 
range of 2,4 to 87,8. The average age of respondents in this study was 32,33 years and 9 
respondents (6,52%) showed a mild degree of airflow obstruction (Acutt, 2004).  
 
According to a study done in Iran in 2015 on respiratory problems and pulmonary function 
indexes among cement industry workers, a higher percentage of workers exposed to dust 
revealed recurrent and prolonged wheezing, coughing, bronchitis, phlegm, sinusitis, 
dyspnoea, shortness of breath and bronchial asthma (Rafeemanesh et al., 2015). When 
compared to controls, the cement factory workers had a higher prevalence of chronic 
respiratory symptoms, however no significant differences in lung function were found 
between production workers and controls (Rafeemanesh et al., 2015). 
 
There was no dose-response-related increase in symptoms or a decrease in lung function 
indices. The prevalence of symptoms and mean pulmonary function indices were similar 
for the exposed workers and controls (Rafeemanesh et al., 2015). Therefore, these 
conclusions did not support the hypothesis that cement dust exposure negatively affected 
lung function or increased respiratory symptoms. Another study conducted in Iran in 2012 
revealed that there were insignificant differences in the major confounding variables of 
demographics (height - p-value 0.7; age - p-value 0.37 and weight - p-value 0.4), cigarette 
smoking (p-value 0.7) and duration of work (p-value 0.51) between exposed and unexposed 
subjects (Kakooei et al., 2012). Workers who work in the crusher and packing areas were 
found to be exposed to high concentrations of respirable cement dust (30.17 mg/m3 and 
27.72 mg/m3), while workers in the cement mill and maintenance areas were exposed to 
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the lowest concentration (5.4 mg/m3). Previous studies support the notion of variation in 
dust exposure in different parts of the same factory. The frequency of coughing, wheezing, 
chronic phlegm and dyspnoea among the exposed workers was higher than that of the 
control group when compared to other findings, but these differences were statistically 
insignificant (Kakooei et al., 2012). Low sample size may explain these results. 
 
An association between lung function decline and cement dust concentrations among 
workers suggests that the respiratory health of roofing cement workers should also be 
protected. The non-significant difference in pulmonary impairments and dust exposure may 
be due to a low concentration of dust exposure and low tenure (Thepaksorn et al., 2013). 
Workers are at a higher risk of developing dust exposure induced health outcomes since 
more than 50% of  exposed workers seldom use personal protective equipment (PPE) such 
as protective dust masks (Thepaksorn et al., 2013).  
A study conducted by Sivaharini, Preetha and Priya (2018) evaluating the pulmonary 
function test among construction workers suggested that the pulmonary function tests FVC, 
FEV1, FEV1/FVC and PEF were significantly different, with FVC having a p-value of 0.55 
and FEV1 having a p-value of 0.5. Khash (2008) showed the following results: 12.8% of the 
exposed workers had grade III dyspnoea, compared to 4.2% of the unexposed. This 
difference was statistically significant (p<0.05). Since cigarette smoking is a major 
confounder for respiratory symptoms, particularly coughing and phlegm, a logistic 
regression analysis was done for each of the respiratory symptoms the workers presented 
with, in addition to chronic bronchitis as an outcome variable. Cough and phlegm that 
presented with shortness of breath (or the absence of shortness of breath) were significantly 
related to dust concentrations. Chronic bronchitis was observed to be statistically significant 
to dust concentrations (Mirzaee et al., 2008). Lung function tests measuring the pulmonary 
functions of workers exposed to dust compared to those who were not exposed to dust 
showed a significant decrease in vital capacity (VC), forced vital capacity (FVC), FEF25-75 
and FEV1 (p<0.05). The exposed group showed suggestive symptoms of restrictive 
disease. The FEV1/FVC percentages in both groups were insignificantly different  (Mirzaee 
et al., 2008). 
Additionally, a study conducted in Congo’s central province on the prevalence of COPD 
amongst workers exposed to cement dust revealed that working in different areas that are 
exposed to different changing levels of cement dust is significantly associated with an 
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increased prevalence of COPD (Mbelambela et al., 2018). High risk factors were detected 
among workers allocated in the transportation, cleaning and production areas. Hence, it is 
imperative that measures are put in place to protect cement factory workers, especially 
those working on the above tasks. Individual preventive measures such as wearing 
particulate respirator masks and regular screening for lung disease is very important and 
highly recommended. Collective preventive measures including maintenance of machines, 
enclosed belt transportation, replacement of pneumatic cleaning machines with automatic 
cleaning machines, wet dust suppression during cleaning activities, and improvement of 
local exhaust ventilation systems in the production area are necessary standard operating 
procedures for reducing the risk of COPD among all exposed workers (Mbelambela et al., 
2018). 
2.5 Conclusion 
The Air Quality Act (AQA) (2004) is detailed on the Bill of Rights contained in the 
Constitution of South Africa (1996). The Constitution specifies the rights of all people in the 
country and outlines the democratic values of human dignity, equality, as well as freedom. 
It is the responsibility of the state to respect, protect, promote and fulfil rights as they are 
detailed in the Bill of Rights. The Constitution (Section 24) explains that everyone has the 
right to an environment that is not harmful to their health or well-being;  to have their 
environment protected for the benefit of present and future generations through reasonable 
legislative and other measures that prevent pollution and ecological degradation; as well as 
to promote conservation and secure ecologically sustainable development and the use of 
natural resources while promoting justifiable economic and social development (Notice, 
2018). In order for these rights to be protected and respected at all times in the context of 
air quality, it is necessary to ensure that the levels of air pollution are not harmful to human 
health or well-being, meaning that ambient air quality standards should be achieved (Notice, 
2018).  
The deposition of cement dust particles in the  respiratory tract can reduce pH, resulting in 
irritated mucous membranes. Chronic respiratory diseases represent both a financial and 
public health challenge for industrialized and developing countries. Chronic respiratory 
symptoms are more prevalent among workers in developing countries, where occupational 
health and safety measures are less of a priority. This is supported by the results of a study 
that determined the prevalence and factors affecting chronic respiratory symptoms among 
workers in Dejen cement factory in 2015 (Gizaw, Yifred and Tadesse, 2016). According to 
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Gizaw et al. (2016), pre-employment and in-service training, smoking cessation 
programmes and improved hygiene practices are important  factors to consider in order to 
maintain the health of workers.  
The next chapter will discuss the study methodlogy, i.e. the procedures and processes 
involved in conducting the study, including ethical considerations for the study, data 
collection, analysis and data reporting. 
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CHAPTER 3 
METHODS AND MATERIALS 
 
In Chapter 1 and 2, an outline of the objectives of this study and a review of previous 
literature from around the world was provided. The literature review also explored the 
different research methodologies employed by previous studies, outlined their findings, and 
discussed the recommendations made by these studies in order to improve chronic 
respiratory symptoms. In this chapter, the research methodology used in this study will be 
discussed. This includes an overview of the current study’s research design, target 
population, sampling methods, study site, data collection techniques, the validity and 
reliability of the research instruments used, ethical considerations and data analysis 
procedures.  
 
3.1 Research methodology 
The following methodological considerations were adopted in the execution of this study: 
 
3.2 Study design 
This study adopted a quantitative, descriptive and cross-sectional research design. A 
descriptive, cross-sectional study was conducted to examine the relationship between 
exposure to cement dust and prevalence of respiratory illnesses. Baseline data for this 
investigation was gathered between August 2018 and October 2018. The data comprised 
of information from spirometric measurements, questionnaire data and walk-through 
observations.  
 
3.3 Research setting 
This study took place in Johannesburg. Company 1 was based in Roodepoort and 
Company 2 was based in Booysens in the Gauteng Province, South Africa (see Figure 1). 
Johannesburg has seven regions (Region A – Region G). Company 1 is situated in Region 
C and Company 2 is based in Region F. These regions are home to various mines and 
mine dumps, and the sampled industries are substantive generators of dust due to typical 
cement processes which are known to be very dangerous to the respiratory system, hence 
they were chosen as the areas under investigation (Johannesburg Roads Agency, 2014). 
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Permission to conduct this research was sought and granted from the two cement-
manufacturing companies (Annexure D). This study took place in a natural setting or real-
life environment, and no manipulation or change to the environment was made in the two 
cement companies that were selected. 
 
 
Figure 1: Location of the companies that participated in this study (Hunadi Mokgalaka, 
2014). 
Company2 
2 
Company1
1 11111  11 
16 
3.4 Population and sample selection 
The study sample included 81 participants who were working in the sampled cement 
companies and were exposed to cement dust. The sample included both male and female 
participants of all ages from the two cement companies. In this study, the participants were 
selected using systematic random sampling. Random sampling was conducted to prevent 
any biases in the participant selection process. An alphabetical list of all workers was 
obtained from the companies and every fifth worker on the list was selected to participate 
in the study. This systematic sampling rationale was used so that every worker had an equal 
possibility of being chosen. All male (88.9%) and female (9.9%) workers of different ages 
that were exposed to cement dust were included in the study. Workers who had a history 
of, or existing respiratory disease and who brought a letter from the treating physician 
confirming diagnosis were excluded from this study as this would have had a negative 
impact on the true reflection of the prevalence of chronic respiratory symptoms.  
3.5 Data collection 
The researcher and two trained fieldworkers (Zulu and Tswana speaking) were actively 
involved in the data collection process. All participants were assisted to complete the 
questionnaire so that they understood what the study was about and also to prevent any 
misunderstandings. English was used as the language medium and in cases where 
participants did not understand English, their preferred language was used. In most cases, 
the preferred language of participants was IsiZulu. A walk-through was conducted at both 
companies to observe worker practices regarding the use of PPE. 
3.5.1 Piloting of the study 
In order to test the practical aspects of the research study, the researcher conducted a pilot 
study to investigate the practicality of the proposed examination and to distinguish potential 
issues in the information gathering instruments, for instance unclear instructions or wording 
and inadequate time allocations (Brink, 2006). A pilot study was conducted using 10 
participants who also work in the cement industry different from the sampled companies, 
and the results of this pilot study did not form part of the main study. Piloting the study was 
essential as the questionnaire was compiled by the researcher and needed to undergo a 
trial run to see if participants could comprehend it before it was executed. Based on the 
findings of the pilot study, the wording on the questionnaire was adjusted to be more specific 
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to the research at hand. Respiratory symptoms were added, such as stuffy nose, which 
were not initially included because more than 60 percent of the participants reported 
experiencing this. Previous medical tests were also made to be more specific to the 
respiratory system, and this alteration was due to the responses of the workers that 
participated in the pilot study.  
3.5.2 The following tools were used to collect data for this study 
3.5.2.1 Tool 1 – Questionnaire 
Information was gathered using a questionnaire that consisted of both closed and open-
ended questions. The questionnaire was developed based on a literature review of 
previous cement exposure studies. The daily experiences of respiratory system 
complaints were used to obtain information on occupational history, demographics, 
smoking history and any acute or chronic respiratory symptoms. The questionnaires were 
administered at participants’ place of employment and took approximately 10 to 20 minutes 
to complete.  
 
3.5.2.2   Tool 2 - Physical examination 
The body weight of every participant was measured using an electronic scale and their 
height was measured using a height meter. These measurements were taken with shoes 
off, pockets emptied and with indoor clothing. Blood pressure measurement was assessed 
using an electronic sphygmomanometer, and this was administered in a sitting position after 
the participant had rested for at least one minute. The following participant data was also 
recorded for performing the spirometry:  
 Age – FVC (Forced Vital Capacity) and flow rate is known to decline with age due to the 
natural deterioration of lung tissue. Considering age prior to performing a spirometry test 
is therefore crucial. 
 Height - According to the OCSA Spirometry Manual (2013), increased lung volumes are 
usually seen with increased height. This is due to an increase in the number or size of 
alveoli relative to airways. Height was also measured with feet together, standing as tall 
as possible.  
 Gender - This variable was recorded for accuracy of results, as males have a larger lung 
volume than females. This difference arises during puberty.  
 Race – This variable was recorded prior to spirometry testing. Evidence suggests that 
South African indigenous populations show similar or higher FEV1/FVC% (Forced 
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Expiratory Volume in one second / Forced Vital Capacity %) and a slower FVC and 
FEV1 compared to Europeans (OCSA, 2013). 
3.5.2.3   Tool 3 - Lung function test (Spirometry)  
As part of the study, pulmonary function parameters were measured. Lung function tests 
were conducted using an electronic spirometer, and emphasis was placed on forced 
expiratory volume and forced vital capacity. The lung function tests were conducted after 
the instruments were successfully calibrated. The researcher did all interpretation, as she 
is a qualified occupational health practitioner by profession and has extensive training on 
lung function testing. 
 
To take a spirometry test, you sit and breathe into a small machine called a spirometer. The 
test works by measuring airflow into and out of your lungs. This medical device records the 
amount of air you breathe in and out and the velocity of your breath. Thus it can assess 
how well your lungs work by measuring how much air you inhale, how much air you exhale 
and how quickly you can exhale it (OCSA, 2013). This is used to diagnose Asthma, Chronic 
Obstructive Pulmonary Disease (COPD) and other conditions that affect breathing. To 
prepare for a spirometry test, you should wear loose-fitting garments that will not meddle 
with your capacity to take a full breath.  Abstain from eating an enormous meal before you 
test so that it will be easier to breathe. A spirometry test requires you to breathe into a 
spirometer. Before the test is done, a nurse or a technician gives specific instructions on 
how to do a spirometry. One needs to listen carefully and ask questions if anything is 
unclear as this is necessary for accurate results.  
 
An individual needs to be seated when the test is being carried out, a clip will be placed on 
your nose to keep your nose shut. You will take a deep breath out as hard as you can for 
several seconds into the spirette tube. The lips should create a seal around the tube so that 
no air leaks out. The test must be done at least 3 times to make sure your results are 
relatively consistent. If there is too much variation among the three outcomes, one may 
need to repeat the test again. 
 
Forced Expiratory Volume was measured and secondly using (FEV1) and FEV1/FVC 
ratios. This was done using a DMS spirometer after it was successfully calibrated 
(Calibration Certificate – Annexure K). Before performing a spirometry, the test procedure 
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was explained and demonstrated to the participants. They were asked to follow procedure 
instructions from the American Thoracic Society (ATS) guidelines (1995), which include no 
heavy physical exercise for 30 minutes, no use of corticosteroids medication for 1 day and 
no cigarette smoking for 1 hour prior to the test. The ATS recommendations on the 
acceptability and reproducibility of the tests were followed, including the duration of 
exhalation for at least 6 seconds for adults. All the participants with dentures were asked to 
remove the dentures before the test and where participants had tight or restrictive clothes 
on, they were asked to loosen them.  
The following contra-indications for performing the spirometry test were taken into 
consideration: 
Recent myocardial infarction; unstable angina; known aneurism; uncontrolled hypertension; 
blood pressure above 180/110 mmHg and a pulse above 110 beats per minute; recent 
cerebrovascular accident (stroke); Haemoptysis (coughing up blood); recent surgery of the 
eye, abdomen or chest; pneumothorax; pulmonary embolism; as well as pregnancy 
complications such as placenta praevia and glaucoma were considered.  
To maintain hygiene and infection control, the spirometry test was done in a well-ventilated, 
temperature-controlled room. All work surfaces and equipment were cleaned and 
disinfected on a daily basis. A new disposable mouthpiece was used for every subject 
tested, and once the participant had placed their mouth over the mouthpiece, they were 
asked not to touch it. After the test was conducted, participants were asked to remove the 
mouthpiece and dispose of it in a red plastic bag reserved for medical waste. All medical 
waste generated was then taken back to U-Care Medical Centre for correct disposal. 
3.5.2.4   Tool 4 - Walk-through observations 
Company 1: During the walk-through, it was observed that a majority of workers in 
Company 1 were using their respiratory protection gear, which in this case was a dust mask 
during working hours. They also knew why it is important to wear their PPE. There was a 
policy on PPE in place and they mentioned that they usually have a toolbox talk on how 
important it is to adhere to the PPE provided. They had very strict rules and regulations on 
PPE. 
Company 2: It was observed that a majority of the workers at this company were not 
wearing their respiratory protection gear because they felt that their dust masks are not 
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effective in preventing dust penetration.  Thus they felt that there was no need to wear their 
respiratory protection gear. Most of the workers had the masks on their neck and some in 
their pockets. The increased amount of dust was the only factor that prompted the use of 
the dust mask, but a majority of workers did not adhere to the policy of PPE.  
3.5.3 Calibration 
The spirometer was switched on and left for about 15 to 20 minutes to warm up. The date 
displayed on the laptop was checked every time a calibration was done to ensure that the 
correct date was displayed. Ambient conditions such as temperature, barometric pressure 
and humidity readings were entered. The 3 L syringe was then firmly connected into the 
sensor and the syringe filled completely with air.  The maximum volume of air filled smoothly 
and completely into the spirometer, and this was done at least 3 times at a flow rate that 
differs between 0.5 L/s and 14 L/s. The spirometer was calibrated before testing 
commenced, as well as every 3 to 4 hours each day depending on the number of 
participants seen on that day. Calibration was repeated when temperature varied by 2℃  or 
more, after a power failure, if the sensor had been dropped, after the spirometer had been 
moved to another room or location, after a thunderstorm and when the sensor was changed 
(Annexure F – Calibration). The spirometric test was conducted after successfully 
calibrating the syringe.  
 
3.6  Data management, processing and data analysis 
3.6.1 Data management and processing  
Data was captured using Microsoft Excel and imported into the Statistical Package for 
Social Sciences (SPSS) software package (Version 25) for cleaning, re-coding and 
analysis. The double entry of data was done to prevent any misinterpretation and mistakes. 
Data management includes data entry, data editing, data coding, data cleaning and data 
description (Brink, 2006). Data editing was done to ensure accuracy, consistency and 
completeness. Data cleaning involves checking for duplicates or missing data, as well as 
renaming and re-coding relevant variables. Continuous variables that were required in 
categorical form were categorized. Exploratory analysis was done using graphical methods 
like box plots and histograms to be able to summarize the main characteristics of the data 
and to identify outliers, trends and data patterns in the dataset. Normal probability plots and 
histograms were used to determine the distribution of all continuous variables. Descriptive 
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analysis was conducted by populating frequencies, tables and charts. Post-coding of 
quantitative data was conducted to analyse close-ended questions. The data from open-
ended questions was grouped based on the answers that workers gave for precise 
interpretation, the data was tabulated and categorized, and finally a text analyser was used 
to group similar answers. Lastly, a description of the data was done in meaningful terms to 
obtain answers to the research questions presented. 
3.6.2 Data analysis 
All 81 participants were included in the analysis. Three participants from Company 1 were 
unable to do their lung function test because they were too busy, but consented (Annexure 
B) to participate and complete the questionnaire. The baseline characteristics for each 
group were summarized using median and interquartile ranges for all continuously skewed 
data, and simple proportions with confidence intervals were determined using exact 
methods for categorical variables. Continuous variables were compared using Wilcoxon 
rank sum test between the two groups. Two-way comparisons of the frequencies of 
categorical data were done using Pearson’s chi squared-tests, where the expected value 
is greater than or equal to 5; and Fischer’s exact test was used where the expected cell 
value is less than 5. Since the study was aimed at determining prevalence, odds ratios were 
calculated and a significant value of 0.05 was used. A p-value of <0.05 was considered to 
be significant in all analyses. 
Factors associated with any respiratory symptoms (for example sneezing, coughing, 
wheezing, etc.) were determined between companies using logistic regression. Pearson 
and Spearman correlation co-efficient were used to assess the association between the 
lung function test and variables such as age, work history, number of cigarettes smoked 
per day and body mass index (BMI). The data from open-ended questions was tabulated 
and categorized, and then a text analyser was used to group similar answers. 
 
The following guide (Table 1) was used for grading spirometric results to quantify 
impairment. 
 
 
Table 1: Guide for grading spirometric results to quantify respiratory impairment (OCSA 
spirometry manual, 2013). 
 
 
22 
 
Parameter Normal Mild1 Moderate2 Severe3 
% pred FVC ≥80 60-79 51-59 ≤50 
% pred FEV1 ≥80 60-79 41-59 ≤40 
FEV1/FVC% ≥80 60-79 41-59 ≤40 
1 Able to meet physical requirements of most job tasks 
2 Diminished ability to meet physical requirement of most tasks 
3 Unable to meet physical requirements of most tasks 
 
This table was used to grade the results of the lung function test (spirometry). The grading 
that was used was either normal, mild, moderate or severe. Referrals for further tests were 
also based on this grading. 
 
3.7  Ethical considerations (Clearance number: REC-01-21-2018) 
 
For this study, the researcher considered the following ethical principles: 
3.7.1 Permission to conduct the study 
The research proposal was submitted to the University of Johannesburg’s Faculty of 
Academic Ethics Committee (Annexure G) and Higher Degrees Committee (Annexure F) 
for review and approval. Permission was obtained from both cement companies that 
participated in this study (letters not attached due to confidentiality reasons but available 
on request). No participant was allowed to participate in this study without written 
permission from his or her employer and a signed participant consent form. 
3.7.2 Confidentiality, privacy and anonymity 
The questionnaire used for data collection ensured anonymity - no participant names were 
written on the questionnaire and only unique identifiers were used. The questionnaire 
assigned numbers to different participants and data was recorded in an aggregate form. 
The data from lung function tests was deleted from the laptop after being printed. 
Data was collected and stored in a locked cabinet. Data will be stored for a period of five 
years and thereafter, it will be destroyed. The researcher also used a personal laptop to 
write up the report and ensured that this laptop was locked at all times when not in use to 
ensure confidentiality. All information was kept private, confidential and anonymous.  No 
personal details of any participant were published in this study. To ensure that the results 
of this study did not pose any negative consequences on the social standing of the cement 
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companies under study, details about the companies were not published in the results of 
this study.  
3.7.3 Provision of debriefing, counselling and additional information 
All participants were counselled prior to the lung function test, and all the participants that 
showed abnormalities on their lung function test were referred to the relevant health 
departments for further tests and assessments. 
3.7.4 Informed consent 
All participants were required to sign a consent form prior to participating in this study 
(Annexure B). The fundamentals of the study were explained to participants through an 
information letter (Annexure A). Participants were also encouraged to ask for clarification if 
they were unsure of anything.  
3.7.5 Provision of debriefing, counselling and additional information 
Participants were protected from any discomfort and harm - be it physical, spiritual, 
emotional, economic, legal or social – by the provision of a debriefing and counselling 
session facilitated by the researcher, as she is a trained practitioner by profession. 
Participants were not paid for taking part in this study. The study results were 
communicated to all participants, companies and contributors before the official publication. 
3.7.6 Right to withdraw and right to no harm 
Participants were informed that they had the right to withdraw from the study at any time 
during the course of the research. Participants were not compelled to remain in the study, 
and were free to withdraw at any time should they wish to do so.  
3.8 Validity and reliability 
Throughout the research, validity and reliability were ensured by applying recognised and 
acceptable statistical procedures and methods. The researcher further ensured that the 
questionnaire (Annexure C) was pre-tested or piloted for reliability and validity issues.  
 
 
3.9 Presentations and publications 
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3.9.1 Presentations 
Part of the study was presented on 3 August 2018 at an Occupational Health and Safety 
Mastermind Session event held at U-Care Medical Centre in Park Station, Johannesburg. 
3.9.2 Publications 
Two articles were drafted and will be submitted to accredited journals for publication. One 
is a study protocol and the other is related to the outcomes of the study.  
 
In this chapter, the research methodology employed in this study was discussed. The next 
chapter will focus on a discussion of the study findings. The conclusion and limitations of 
the study will be discussed in Chapter 5. 
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CHAPTER 4 
RESULTS 
 
In this chapter, the results of the study are discussed in detail. The results are structured 
according to the specific objectives of this study, and they also reflect the results of the 
analyses that were conducted to explore bias and control for confounding factors.  
 
Table 2 below represents clinical data and the demographic characteristics of the study 
participants. Demographic and clinical characteristics include age, gender, ethnicity, 
highest level of education, working history, blood pressure, pulse rate, smoking habits, 
smoking history, average cigarettes smoked per day, body mass index and the place of 
residence of participants. Participants were also asked if they have suffered any respiratory 
problems due to previous employment; personal protective equipment used and how often 
this was changed; as well as loss time injury due to respiratory disease. 
 
Table 2: Clinical and demographic characteristics of the study participants 
Characteristics  Company 1 (%) 
N=31 
Company 2 (%) 
N=50 
Age (median) 
<30 years 
30-40years 
≥40years 
39 (31-49) 
3 (9.68) 
13 (41.94) 
15 (48.39) 
37 (33-47) 
6 (12.00) 
23 (46.00) 
21 (42.00) 
Gender 
Female 
Male  
 
4 (12.90) 
27 (87.10) 
 
4 (8.16) 
45 (91.84) 
Ethnicity 
Black 
White 
Coloured 
Indian/Asian 
 
31 (100) 
0 (0.00) 
0 (0.00) 
0 (0.00) 
 
38 (96.00) 
2 (4.00) 
2 (4.00) 
8 (16.00) 
Highest level of education 
Grade 11/standard 9 or lower  
Grade 12 (Matric, standard 10) 
Post Matric Diploma or 
certificate 
 
14 (45.16) 
11 (35.48) 
6 (19.35) 
 
17 (34.00) 
29 (58.00) 
4 (8.00) 
Work History 
<3 years 
3-5 years 
5-10 years 
>10 years 
N=30 
4 (13.33) 
3 (10.00) 
12 (40.00) 
11 (36.67) 
N=49 
12 (24.49) 
20 (40.82) 
14 (28.57) 
3 (6.12) 
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Characteristics  Company 1 (%) 
N=31 
Company 2 (%) 
N=50 
Blood pressure (Median) 
Systolic 
Diastolic 
 
132.00 (120-139) 
77.00 (74-85) 
 
134 (120-140) 
84 (74-90) 
Pulse (Median) 71.00 (66-81) 75.00 (67-80) 
Smoking habit 
Yes 
No 
Missing data 
 
7 (22.58) 
23 (74.19) 
1 (3.23) 
 
20 (40.00) 
29 (58.00) 
1 (2.00) 
Median cigarettes per day 10.00 (3-15) 10.00 (5.5-18) 
Smoking History  
(Median years) 
1-10 
10-20 
>20 
Missing 
 
19.00 (9-28) 
2 (6.45) 
2 (6.45) 
3 (9.68) 
24 (77.42) 
 
16.00 (8.5-21) 
5 (10.00) 
8 (16.00) 
7 (14.00) 
30 (60.00) 
Average cigarettes per day 
<10  
≥10 
Missing 
 
3 (9.68) 
4 (12.90) 
24 (77.42) 
 
9 (18.00) 
11 (22.00) 
30 (60.00)  
BMI 
Underweight 
Normal 
Overweight 
Obese 
Missing 
 
0 (0.00) 
13 (41.94) 
6 (19.35) 
12 (38.71) 
0 (0.00) 
 
1 (2.00) 
23 (46.00) 
14 (28.00) 
11 (22.00) 
1(2.00) 
Area of residence 
Suburb 
Township 
 
7 (23.33) 
23 (76.67) 
 
16 (34.78) 
30 (65.22) 
Suffered respiratory problems 
due to previous employment 
Yes 
No 
 
 
0 (0.00) 
29 (100.00) 
 
 
4 (8.00) 
46 (92.00) 
Personal Protective 
Equipment 
Used (PPE) - Mask 
Yes 
No 
 
 
 
30 (96.8) 
1 (3.2) 
 
 
 
23 (46.0) 
27 (54.0) 
How often was the mask 
changed? 
Daily 
Weekly 
Monthly 
None 
 
 
29 (93.55) 
0 (0.00) 
0 (0.00) 
2 (6.45) 
 
 
 
10 (21.41) 
8 (16.33) 
2 (4.08) 
29 (59.18) 
 
 
 
27 
 
 
Characteristics  Company 1 (%) 
N=31 
Company 2 (%) 
N=50 
Loss time due to respiratory 
disease 
Yes  
No 
Missing data 
 
 
0 (0.00) 
22 (71.0) 
9 (29.0) 
 
 
3 (6.0) 
41 (82.0) 
6 (12.0) 
 
4.1 Study population characteristics 
A total of 81 workers from two different cement factories were interviewed, examined and 
underwent a pulmonary function test. For both companies, a majority of the workers were 
males - 87% in Company 1 and 91% in Company 2. Median age was 39 years (IQR 31-49) 
and 37 years (IQR 33-47) in Company 1 and Company 2 respectively.  In Company 1, 
19.35% of the workers had a post matric Diploma as their highest level of education while in 
Company 2, 8% of workers had a post matric Diploma as their highest level of education. A 
majority of workers in Company 1 had worked for the cement company for over 5 years 
while in Company 2, a majority worked for the company for over 3 years. 22.58 % of workers 
in Company 1 reported being smokers at the time of data collection, while 40% reported 
being smokers in Company 2. Among those that reported being smokers, the median 
number of cigarettes smoked was 10 (3-15) and 10 (6-15) in Company 1 and Company 2 
respectively. The median for smoking history was 19 years (9-28) in Company 1 and 16 
years (8.5-21) in Company 2. Out of the 20 participants who reported being smokers in 
Company 2, 16% had been smoking for over 10 years and most workers (12.9%) smoked 
an average of 10 cigarettes per day. In Company 2, a majority of the workers (22%) had 
been smoking for over 20 years and smoked an average of 10 cigarettes per day. 
 
In Company 1, a majority of participants had normal body mass index (41.94%), 19.35% 
were overweight and 38.71% were obese. In Company 2, most participants had normal BMI 
(46%) and only one person was underweight (2%), 28% were overweight and 22% were 
obese. In both companies, a majority of participants were residing in townships and that 
included informal settlements - 76.67% in Company 1 and 65.22% in Company 2.  No one 
stated that they had suffered respiratory problems due to previous employment in Company 
1, and only 8% have suffered respiratory problems as a result of previous employment in 
Company 2. The use of PPE (dust masks) was 96.8% and 46% in Company 1 and 
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Company 2 respectively. A majority of workers in Company 2 (54%) were not using dust 
masks, even though these were provided, because they felt it was not effective to use. In 
both companies, most participants changed their mask daily, 93.55% in Company 1 and 
21.41% in Company 2. 71% of the participants in this study did not have any loss time due 
to respiratory disease in Company 1, compared to 82% in Company 2. Both companies had 
policies in place regarding personal protective equipment use. Company 1 had very strict 
rules on PPE use. 
4.2 Clinical results 
The median systolic blood pressure for workers in Company 1 was 132 (120-139) mmHg, 
whereas in Company 2 it was 134 (120-140) mmHg. The median pulse rate of workers in 
Company 1 was 71 (66-81) and 75 (67-80) for Company 2. In Company 1, 41.35% of 
workers had a normal body index (BMI), 19.35% were overweight, and 38.71% were obese. 
In Company 2, 46% of the workers had a normal BMI, 2% were underweight, 28% were 
overweight, and 22% were obese. In both companies, 76.67% (Company 1) and 65.22% 
(Company 2) of participants resided in informal settlements. Only 8% suffered respiratory 
problems because of previous employment history in Company 1. 93.55% of workers in 
Company 1 and 46% in Company 2 wore dust masks. In Company 1, 93.55% of workers 
changed their mask daily, while only 21.41% reported changing their mask daily in 
Company 2.  
A total of 71% in Company 1 and 82% in Company 2 had not reported any loss time due to 
respiratory disease and injuries. In Company 1, 80.6% of workers reported having 
underwent chest x-rays before, and this was part of their annual medical surveillance. In 
Company 1, only 64.5% have consulted a medical practitioner regarding respiratory 
symptoms and 77.4% of workers confirmed having done blood tests regarding respiratory 
symptoms. Historically, in Company 2, 56% of workers have done chest x-rays before, 
14.0% have done blood tests and 26% reported having consulted a medical doctor before 
regarding respiratory symptoms. 
 
Table 3 below shows all the clinical respiratory signs and symptoms that workers 
presented with, this data includes both the exposed and non-exposed groups. 
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Table 3: Reported symptoms of respiratory system 
Clinical Symptoms 
(respiratory) 
Company 1 (%) Company 2 (%) p-value 
Recurring blocked/ 
running nose 
Yes 
No 
 
 
3 (9.68) 
28 (90.32) 
 
 
15 (30.00) 
35 (70.00) 
 
 
 
0.032 
Bouts of coughing 
Yes 
No 
 
7(22.58) 
24 (77.42) 
 
9 (18.00) 
41 (82.00) 
 
 
0.615 
Chest tightness 
Yes 
No 
 
2 (6.45) 
29 (93.55) 
 
9 (18.00) 
41 (82.00) 
 
 
0.140 
Wheezing 
Yes 
No 
 
0 (0.00) 
31(100.00) 
 
7 (14.00) 
43 (86.00) 
 
 
0.029 
Phlegm 
Yes 
No 
 
1(3.23) 
30 (96.77) 
 
7(14.00) 
43 (86.00) 
 
 
0.114 
Chest pain 
Yes 
No 
 
7 (22.58) 
24 (77.42) 
 
9 (18.00) 
41 (82.00) 
 
 
0.615 
Sneezing/stuffy nose 
Yes 
No 
 
4 (12.90) 
27 (87.10) 
 
23 (46.00) 
27 (54.00) 
 
 
0.002 
Fatigue/tiredness 
Yes 
No 
 
6 (19.35) 
25 (80.65) 
 
22 (44.00) 
28 (56.00) 
 
 
0.023 
Rapid breathing 
Yes 
No 
 
0 (0.00) 
31 (100.00) 
 
6 (12.00) 
44 (88.00) 
 
 
0.045 
Recurring 
soreness/watery eyes 
Yes 
No 
 
 
0 (0.00) 
31 (100.00) 
 
 
7 (14.00) 
43 (86.00) 
 
 
 
0.029 
Breathlessness 
Yes 
No 
 
0 (0.00) 
31 (100.00) 
 
7 (14.00) 
43 (86.00) 
 
  
0.145 
Any other persistent 
symptoms or history of 
chest problems 
Yes 
No 
 
 
 
0 (0.00) 
31 (100.00) 
 
 
 
1 (2.00) 
49 (98.00) 
 
 
 
 
0.754 
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Figure 2: Graphical presentation of the table above (Table 3) - Clinical respiratory 
symptoms experienced by workers in Company 1 and Company 2. 
 
Figure 3: Continuation of graphical presentation of Table 3 - Clinical respiratory 
symptoms experienced by workers in Company 1 and Company 2. 
Two workers presented with mild restriction, 1 worker with moderate obstruction and 1 
worker with mild obstruction in Company 1. Company 2 had the most people who presented 
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with abnormal spirometric results that suggested restrictive, obstructive or mixed restrictive-
obstructive spirometry which was either mild, moderate or severe. Emphysema, Asthma, 
Pneumonia, bronchitis and sinusitis were more common among Company 2 workers. Lung 
disease (Tuberculosis) was detected in 1 person from Company 2. One worker reported 
Emphysema in Company 2; while coughing, sneezing, wheezing, recurring blocked nose, 
bouts of coughing, chest tightness, phlegm, chest pain and breathlessness were 
significantly prevalent in both companies (Table 2). About 9.68% of the workers in Company 
1 had recurrent blocked/running nose compared to 30% in Company 2, with a p value of 
0.032.  In Company 1, 22.58% of the workers had bouts of coughing compared to 18% in 
Company 2 (p =0.615). Two workers in Company 1 (6.45%) had chest tightness compared 
to 18% in Company 2 (p =0.140). No one had wheezing in Company 1 and 14% of workers 
experienced wheezing in Company 2 (p =0.029).  
Most workers in Company 2 (14%) reported phlegm, while only 3.23% of workers had 
phlegm in Company 1 (p =0.114). Company 2 also had the most workers (18%) who had 
chest pain compared to 22.58% in Company 1 (p =0.615). In Company 1, 12.90% of 
workers had sneezing/stuffy nose compared to 46% in Company 2 (p =0.002). Forty four 
percent of the workers reported experiencing fatigue in Company 2 compared to 19.35% in 
Company 1 (p =0.023). No one had rapid breathing in Company 1 and 12% of workers had 
rapid breathing in Company 2 (p =0.045). None of the workers had recurring 
soreness/watery eyes in Company 1 compared to 14% in Company 2 (p =0.029). None of 
the workers reported breathlessness or any other persistent symptom or history of chest 
problems in Company 1, whereas 14% of the workers in Company 2 reported 
breathlessness and 2% of workers reported having had other persistent symptoms or a 
history of chest problems.  
 
The table below, Table 4, shows factors associated with respiratory clinical symptoms. 
Linear regression was used to measure the association between respiratory symptoms 
and risk factors. 
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Table 4: Factors associated with clinical symptoms (respiratory) 
 Unadjusted 
Characteristic  Odds ratio (CI) P value 
Gender 
Female  
Male 
 
1 
2.27 (0.52-9.92) 
 
 
0.275 
Company 
1 
2 
 
1 
1.86 (0.72-4.77) 
 
 
0.198 
Residential area 
Suburb 
Township 
 
1 
1.95 (0.70-5.39) 
 
 
0.199 
Currently smoking 
No 
Yes 
 
1 
6.34 (1.69-23.73) 
 
 
0.006 
Age  
<30 years 
30-40years 
≥40years 
 
1 
2.4 (0.53-10.93) 
1.26 (0.29-5.50) 
 
 
0.258 
0.761 
Work history 
<3 years 
3-5 years 
5-10 years 
>10 years 
 
1 
0.71 (0.18-2.72) 
1.52 (0.37-6.12) 
0.45 (0.12-2.01) 
 
 
0.614 
0.560 
0.299 
Education  
Grade 11/Std 9 or lower 
Grade 12 (Matric, Std 10) 
Post Matric Diploma or certificate 
 
1 
0.39 (0.13-1.13) 
0.68 (0.14-3.34) 
 
 
0.083 
0.636 
Mask 
Yes 
No 
 
1 
0.42 (0.14-1.20) 
 
 
0.104 
How often did they change? 
Daily 
Weekly 
More than one week 
None 
 
1 
2.57 (0.46-14-36) 
Omitted  
3.57 (1.20-10.63) 
 
 
0.282 
 
0.022 
 
Binary logistic regression was used to assess the association between experiencing any 
clinical respiratory symptoms and risk factors. Gender, residential area, age and level of 
education was not significantly associated with having any respiratory symptoms. However, 
workers who reported smoking at the time of data collection were 6.34 times more likely to 
experience any respiratory symptom (CI 1.69-23.73, p = 0.006). 
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A majority of the workers in Company 1 were using masks as a respiratory protective 
measure compared to Company 2 (96.8% and 46.0% respectively). Of those individuals 
who were using masks, 93.55% in Company 1 reported changing their mask daily, while 
21% reported changing their mask daily in Company 2. 
The table below (Table 5) shows the history of respiratory disease among workers who 
participated in the study from both Company 1 and Company 2. 
Table 5: History of respiratory disease 
History of respiratory disease Company 1 (%) Company 2 (%) 
Emphysema 
Yes 
No 
 
 
0 (0.0) 
31 (100.0) 
 
 
1 (2.0) 
49 (98.0) 
Asthma 
Yes  
No 
 
 
0 (0.0) 
31 (100.0) 
 
 
5 (10.0) 
45 (90.0) 
Pneumonia 
Yes 
No 
 
 
0 (0.0) 
31 (100.0) 
 
 
2 (4.0) 
48 (96.0) 
Bronchitis 
Yes  
No  
 
 
0 (0.0) 
31 (100.0) 
 
 
4 (8.0) 
46 (92.0) 
Sinusitis 
Yes 
No 
 
 
3 (9.7) 
28 (90.3) 
 
 
3(9.7) 
47 (94.0) 
Lung disease (Tuberculosis) 
Yes 
No 
 
 
0 (0.0) 
31 (100.0) 
 
 
1(2.0) 
49 (98.0) 
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Figure 4: Graphical presentation of the history of respiratory diseases (Table 5) 
 
Some of the workers who participated in the study from both companies showed the above 
recorded respiratory diseases. Some were also referred for further examination when the 
above diseases were diagnosed. 
In Table 6, lung function tests were analysed using the 3 variables - FEV1 prediction 
percentage, FVC prediction percentage and FEV1/FVC actual percentage. Company 1 was 
compared to Company 2, and p-values were also used to elaborate on the significance of 
the variables. 
 
Table 6: Lung function test results for Company 1 and Company 2 
Variable Company 1 (M± 
SD) N=28) 
Company 2 (M± 
SD) N=31) 
p-value 
FEV1pred 101.07 (16.41) 87.94 (14.50) 0.001 
FEV1/FVC% 80.20 (2.03) 80.07 (1.97) 0.778 
FVC pred 103.50 (15.39) 87.32 (12.26) <0.001 
 
The table above shows that mean FEV1pred and FVC prediction were significantly different 
between the two companies. Company 1 had a high mean FEV1pred (101.07, SD: 16.41) 
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compared to Company 2 (87.94, SD: 14.50) (p =0.001). Mean FVC prediction was 
significantly different between companies. Company 1 had a mean FVC prediction of 103.5 
(SD: 15.39) compared to 87.32 (SD: 12.26) in Company 2 (p =0.001). However, there was 
no difference in mean FEV1/FVC% between the two companies. 
Table 7 was constructed to see if there was a correlation between pulmonary function 
indices (FEV1, FVC and FEV1/FVC%) and demographic characteristics such as age, 
smoking, number of cigarettes smoked, BMI, PPE used and how often it was changed, as 
well as the work history of workers. 
Table 7: The correlation between pulmonary function indices and clinical/demographic 
characteristics 
Variable  FEV1pred_1 FEV1/FVC%_2 FVCpred_1 
Age 
Correlation 
Sig (2 tailed) 
 
0.087 
0.452 
 
0.212 
0.068 
 
-0.027 
0.081 
Smoking 
Correlation 
Sig (2 tailed) 
 
0.212 
0.068 
 
-0.537 
0.007 
 
0.224 
0.053 
Number of cigarettes 
Correlation 
Sig (2 tailed) 
 
-0.569 
0.004 
 
-0.203 
0.342 
 
-0.561 
0.004 
BMI 
Correlation 
Sig (2 tailed) 
 
0.074 
0.524 
 
-0.014 
0.906 
 
0.080 
0.489 
PPE mask 
Correlation 
Sig (2 tailed) 
 
0.312 
0.006 
 
0.099 
0.393 
 
0.352 
0.002 
Change of mask 
Correlation 
Sig (2 tailed) 
 
-0.335 
0.003 
 
-0.073 
0.533 
 
-0.379 
0.007 
Work history 
Correlation 
Sig (2 tailed) 
 
0.209 
0.069 
 
-0.138 
0.234 
 
0.134 
0.249 
 
Table 7 shows spirometric indices between the two companies. Correlation analysis 
showed that FEV1/FVC%_2 had a reverse relationship with smoking (p =0.007). In addition, 
FVCpred_1 and FEVpred_1 had a similar relationship with the number of cigarettes smoked 
per day (p =0.004 and p =0.004 respectively). 
Table 8 below shows all the lung function tests that were found to be abnormal, the job 
description of workers who displayed abnormality, the department that they worked in,  their 
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work history in the current industry, as well as corrective actions taken to further manage 
the abnormality. This data is from both Company 1 and Company 2. Lung function tests 
were used as Tool 3 to achieve one of the objectives of the study. The actions taken to 
correct or minimise the risks associated with abnormal lung function test results are also 
included in the table. 
Table 8: Interpretation of lung function test for Company 1 and Company 2 
Company Lung function 
test 
interpretation 
Job 
Description 
Department Work 
History 
Comments 
1 
Moderate 
obstruction Supervisor 
Packing 
/Packaging 
Plant 
9 years 
Referred for 
bronchodilator 
test, to repeat 
spirometry in 
6 months 
Mild restriction Cleaner Packing Plant Missing Referred for chest x-ray 
Mild 
obstruction Team Leader Packing Plant 
11 
years 
Referred for 
bronchodilator 
test and chest 
x-ray 
Mild restriction Electrician Preventive Maintenance 5 Years 
Referred for 
chest x-ray, to 
repeat 
spirometry in 
6 months 
 
 
2 
 
 
Mild 
obstruction 
and mild 
restriction  
Administrator  Admin 5 Years Referred for chest x-ray 
Mild restriction Sales Representative Sales 5 years 
Referred for 
chest x-ray 
Mild restriction 
and mild 
obstruction 
Director Executive  5 years  Referred for chest x-ray 
Severe 
Restriction  
General 
Worker Production 1 year 
Referred for 
chest x-ray 
and further 
management 
Moderate 
restriction 
Mixer Truck 
Driver 
Transport 
(delivery) 5 years  
Referred for 
chest x-ray, to 
repeat 
spirometry in 
6 months 
 
 
 
 
37 
 
 
Company Lung function 
test 
interpretation 
Job 
Description 
Department Work 
History 
Comments 
 
2 
 
 
 
 
Mild restriction 
 
Pump 
Operator 
Transport 2 years 
Referred for 
chest x-ray, to 
repeat 
spirometry in 
6 months 
Moderate to 
severe 
restriction 
Sales 
Representative Sales 4 years 
Referred for 
chest x-ray, to 
repeat 
spirometry in 
6 months 
Mild restriction General Worker General 
11 
years 
Referred for 
chest-ray 
Mild restriction 
and mild 
obstruction 
Mixer Truck 
Driver 
Transport 
(delivery) 
16 
months 
Referred for 
chest x-ray 
and 
bronchodilator 
test, to repeat 
spirometry in 
6 months 
Mild restriction Mixer Truck Driver 
Transport 
(delivery) 
3 
months 
Referred for 
chest x-ray 
Mild 
obstruction 
Mixer Truck 
Driver 
Transport 
(delivery) 9 years 
Referred for 
bronchodilator 
test, to repeat 
spirometry in 
6 months 
Mild restriction General Worker General 7 years 
Referred for 
chest x-ray, to 
repeat 
spirometry in 
6 months 
 
In the table above, the abnormal lung function test results of workers from both companies 
were captured. In Company 1, 4 workers revealed abnormal results - 2 workers presented 
with mild restriction and 2 workers presented with mild to moderate obstruction. A majority 
of the workers in Company 1 who showed abnormal results were from the Packaging 
Department and had been with the company for over 5 years. Corrective actions were taken 
into consideration to either refer the workers for chest x-rays or bronchodilator tests. They 
were also asked to follow-up in 6 months and to use respiratory protection gear as required. 
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In Company 2, 12 workers showed abnormal lung function test results. A majority of these 
workers presented with mild to moderate restriction in their lung function test results, and 
their work history ranged from 3 months to 11 years. They were also referred for corrective 
actions. 
 
Table 9 below shows whether any of the job descriptions of the workers who participated 
in the study from both companies is associated with any of the respiratory symptoms. 
 
Table 9: Association between job description and respiratory symptoms among cement 
company workers (N=81) 
Symptoms Occupation 
  
Respiratory 
symptom 
Admin (%)  
n=12 
Cleaner 
(%) 
n=13 
Driver (%) 
n=26 
Electrician 
(%) 
n=3 
Maintenance 
(%) 
 n=6 
Operator 
(%)  
n=21 
P-
value 
Bouts of 
coughing 
No 
Yes 
 
 
7 (10.77) 
5 (31.25) 
 
 
8 (12.3) 
5 (31.25) 
 
 
22 (33.85) 
4 (25.00) 
 
 
3 (4.62) 
0 (0) 
 
 
5 (7.69) 
1 (6.25) 
 
 
20 (30.77) 
1 (6.25) 
 
 
 
0.005 
Chest pain 
 
No 
Yes 
 
 
1 (25.00) 
11 (914.67) 
 
 
0 (0.00) 
11 (14.67) 
 
 
3 (75.00) 
23 (30.67) 
 
 
0 (0.00) 
3 (4.00) 
 
 
0 (0.00) 
6 (8.00) 
 
 
0 (0.00) 
21 (28.00) 
 
 
 
0.507 
Blocked nose 
No  
Yes  
 
7 (11.11) 
5 (27.78) 
 
12 (19.05) 
1 (5.56) 
 
1 (28.57) 
8 (44.44) 
 
3 (4.76) 
0 (0) 
 
5 (7.94) 
1 (5.56) 
 
18 (28.57) 
3 (16.67) 
 
 
0.218 
Chest 
tightness 
No 
Yes 
 
 
8 (11.43) 
4 (36.36) 
 
 
12 (17.14) 
1 (9.09) 
 
 
23 (32.86) 
3 (27.27) 
 
 
3 (4.29) 
0 (0.00) 
 
 
5 (7.14) 
1 (9.09) 
 
 
19 (27.14) 
2 (18.18) 
 
 
 
0.455 
Wheezing 
No 
Yes 
 
9 (12.16) 
3 (42.860 
 
13 (17.57) 
0 (0.00) 
 
24 (32.43) 
2 (28.57) 
 
3 (4.05) 
0 (0) 
 
6 (8.11) 
0 (0) 
19 (25.68) 
2 (28.57) 
 
 
0.287 
Phlegm 
No 
Yes 
 
10 (13.70) 
2 (25.00) 
 
13 (17.81) 
0 (0.00) 
 
23 (31.51) 
3 (37.50) 
 
3 (4.11) 
0 (0.00) 
 
5 (6.85) 
1 (12.50) 
 
19 (26.03) 
2 (25.00) 
 
 
0.696 
Chest pain 
No 
Yes 
 
10 (15.38) 
2 (12.50) 
 
8 (12.31) 
5 (31.25) 
 
23 (35.38) 
3 (18.5) 
 
2 (3.08) 
1(6.25) 
 
5 (7.69) 
1 (6.25) 
 
17 (26.15) 
4 (25.00) 
 
 
0.429 
Sneezing/stuf
fy nose 
No 
Yes 
 
 
8 (14.81) 
4 (914.81) 
 
 
11 (20.37) 
2 (7.41) 
 
 
14 (25.93) 
12 (44.44) 
 
 
3 (5.56) 
0 (0.00) 
 
 
5 (9.26) 
1 (3.70) 
 
 
13 (24.07) 
8 (29.63) 
 
 
 
0.344 
Fatigue/ 
tiredness 
No 
Yes 
 
 
8 (15.09) 
4 (14.29) 
 
 
10 (18.87) 
3 (10.71) 
 
 
16 (30.19) 
10 
(935.71) 
 
 
3 (5.66) 
0 (0) 
 
 
3 (5.66) 
3 (10.71) 
 
 
13 (24.53) 
8 (28.57) 
 
 
 
0.73
5 
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Symptoms Occupation 
  
Respiratory 
symptom 
Admin (%)  
n=12 
Cleaner 
(%) 
n=13 
Driver (%) 
n=26 
Electrician 
(%) 
n=3 
Maintenance 
(%) 
 n=6 
Operator 
(%)  
n=21 
P-
value 
          
Rapid 
breathing 
No 
Yes 
 
 
11 (14.67) 
1 (16.67) 
 
 
12 (16.00) 
1 (16.67) 
 
 
25 (33.33) 
1 (16.67) 
 
 
3 (4.00) 
0 (0.00) 
 
 
6 (8.00) 
0 (0.00) 
 
 
18 (24.00) 
3 (5.00) 
 
 
 
0.824 
Soreness/ 
watery eyes 
No  
Yes 
 
 
11(14.86) 
1 (14.29) 
 
 
12 (16.22) 
1 (14.29) 
 
 
24 (32.43) 
2 (28.57) 
 
 
3 (4.05) 
0(0.00) 
 
 
6 (8.11) 
0 (0.00) 
 
 
18 (24.32) 
3 (942.86) 
 
 
 
0.976 
Breathlessne
ss 
No 
Yes 
 
9 (12.16) 
3 (42.86) 
 
12 (16.22) 
1 (14.29) 
 
25 (33.78) 
1 (14.29) 
 
3 (4.05) 
0 (0.00) 
 
6 (8.11) 
0 (0.00) 
 
19 (25.68) 
2 (28.57) 
 
 
0.426 
  
The test above was performed to find out if there is any significant difference between job 
description and respiratory symptoms. The test showed that there is no significant 
difference between job description and respiratory disease, which suggests that there is no 
association between job description and the prevalence of respiratory symptoms (p 
value>0.05). 
The results of the study are structured according to the specific objectives of the study. This 
chapter also reflects the results of the analyses that were conducted to explore bias and 
control for confounding variables. 
 
4.3 Objectives of the study 
4.3.1 Objective 1 
To examine and characterize the health effects that cement dust exposure poses on 
the human respiratory system 
Two workers presented with mild restriction,  1 worker with moderate obstruction and 1  
worker with mild obstruction in Company 1; whereas Company 2 had the most people who 
presented with abnormal spirometric results that suggested restrictive, obstructive or mixed 
restrictive-obstructive spirometry which were  either mild, moderate or severe. Emphysema, 
Asthma, Pneumonia, bronchitis and sinusitis were more common among Company 2 
employees. Lung disease (Tuberculosis) was detected in 1 person from Company 2. One 
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worker reported Emphysema in Company 2; while coughing, sneezing, wheezing, recurring 
blocked nose, bouts of coughing, chest tightness, phlegm, chest pain and breathlessness 
were significantly prevalent in both companies (see Table 2). About 9.68% of the workers 
in Company 1 had recurrent blocked/running nose compared to 30% in Company 2 (p value 
of 0.032).  In Company 1, 22.58% of the workers had bouts of coughing compared to 18% 
in Company 2 (p =0.615). Two workers in Company 1 (6.45%) had chest tightness 
compared to 18% in Company 2 (p =0.140). No one had wheezing in Company 1 and 14% 
of workers experienced wheezing in Company 2 (p =0.029).  
 
Most workers in Company 2 (14%) reported phlegm, while only 3.23% of workers had 
phlegm in Company 1 (p =0.114). Company 2 also had the most workers (18%) who had 
chest pain compared to 22.58% of workers from Company 1 (p =0.615). In Company 1, 
12.90% of workers had sneezing/stuffy nose compared to 46% in Company 2 (p =0.002).  
Forty four percent of workers reported experiencing fatigue in Company 2 compared to 
19.35% in Company 1 (p =0.023). No one had rapid breathing in Company 1, while 12% of 
workers had rapid breathing in Company 2 (p =0.045). None of the workers had recurring 
soreness/watery eyes in Company 1 compared to 14% of the workers in Company 2 (p 
=0.029). None of the workers reported breathlessness or any other persistent symptom or 
history of chest problems in Company 1; whereas 14% of the workers in Company 2 
reported breathlessness and 2% of workers reported having had other persistent symptoms 
or a history of chest problems. 
4.3.2 Objective 2 
To explore factors contributing to respiratory symptoms 
Binary logistic regression was used to assess the association between experiencing any 
clinical respiratory symptom and risk factors. Gender, residential area, age and level of 
education was not significantly associated with having any respiratory symptoms. However, 
workers that reported smoking at the time of data collection were 6.34 times more likely to 
experience any respiratory symptom (CI 1.69-23.73, p =0.006) (see Table 3). Table 4 
shows spirometric indices between the two companies. Correlation analysis showed that 
FEV1/FVC_2 had a reverse relationship with smoking (p =0.007). In addition, FVCpred_1 
and FEVpred_1 had a similar relationship with number of cigarettes smoked per day (p 
=0.004 and p =0.004 respectively). 
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4.3.3 Objective 3 
Evaluate worker practices concerning the use of respiratory protection gear 
A majority of the workers in Company 1 were using masks as a respiratory protective 
measure compared to Company 2 (96.8% and 46.0% respectively). Of those individuals 
who were using masks, 93.55% in Company 1 reported changing their mask daily while 
21% reported changing their mask daily in Company 2. During the walk-through it was 
observed that a majority of workers in Company 1 adhered to the respiratory protection 
gear at all times, whereas workers in Company 2 did not see the need to use their dust 
masks because they felt that it was not effective in protecting dust penetration – thus a 
majority of workers had the mask on their neck or in their pockets.  
4.4 Discussion 
This study was performed in two cement industries based in the Gauteng Province, South 
Africa. It is aimed at determining the prevalence of chronic respiratory symptoms among 
workers who are exposed to cement dust. The participants, with the help of a researcher 
and two fieldworkers, completed a questionnaire with demographic information and 
respiratory clinical symptoms information. Information from the questionnaire was captured 
on SPSS and then analysed by means of tables. Spirometry was also performed in order 
to elaborate further on the lung function tests. Spirometry is often performed in clinical or 
occupational settings. In an occupational setting, it is considered an important test in 
medical surveillance to examine and diagnose pulmonary diseases. Most of the time, the 
interpretation of the lung function test depends on the predictions of a healthy individual. 
The results of this study highlighted important values and predictions. The values that this 
study focused on were Forced Vital Capacity (FVC), Forced Expiratory Volume over 1 
second, as well as FEV1/FVC% ratio. 
 
Respiratory diseases associated with inhalation of respirable airborne dust are the most 
prominent group of occupational diseases (Blanc et al., 2009). Previous study subjects who 
suffer from Chronic Obstructive Pulmonary Disease (COPD) are of the opinion that 
workplace exposure is associated with an increased risk of COPD (Karkhanis and Joshi, 
2011).  It has been recorded on a previous study by Rahmani et al. (2018) that chronic 
respiratory diseases account for most of the public health challenges in both developing 
and industrialised countries due to the health and economic challenges they pose (Aїt-
khaled et al., 2001).   
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Cement is one of the most useful and frequently used building materials, especially in South 
Africa.  Portland cement is composed of calcium oxide, aluminium trioxide, silicon dioxide, 
ferric oxide, dicalcium silicate, magnesium oxide, selenium, thallium and a low 
concentration of hexavalent chromium. Workers in cement factories are usually exposed to 
different health hazards during cement production and handling, including exposure to 
cement dust, high temperatures and noise. However, the major occupational hazard in the 
cement production industry is respirable dust particles which are emitted into the 
environment, this includes the atmosphere and the cement dust that settles on the floor or 
the ground during most stages of the production process (with higher concentrations in the 
crane, packing and crusher departments that can ultimately cause infections and  various 
lung diseases, including chronic bronchitis, Asthma, lung cancer, Pneumonia and 
Tuberculosis) (Aminian et al., 2013). In one of the previous studies that was mentioned in 
the literature review, it was found that Iranian workers showed an increased prevalence of 
respiratory symptoms, and reduced lung function indices were noticed post-shift during the 
course of the study (Aminian et al., 2013). 
 
In this study, it was found that various types of health complications were present among 
participants - such as emphysema, bronchitis and Tuberculosis. Similar to the findings of 
Mwaiselage et al. (2006), another finding from this study concluded that acute respiratory 
health effects among workers are due to exposure to high concentrations of irritant cement 
dust. The results of the current study confirmed that the prevalence of respiratory symptoms 
was higher among the workers who were exposed to cement dust and those who smoke, 
while results among workers who were smokers were statistically significant.  
 
A study based on Malaysian participants reported an association between total dust 
exposure and respiratory symptoms such as cough, phlegm, chest tightness and also lung 
function indices (Noor et al., 2000). Another study reported that dysplasia, squamous 
metaplasia and acute inflammatory infiltrated cells were detected (Hommi et al., 2013). The 
strength of the current study includes the availability of the spirometry, which was conducted 
to further confirm any respiratory symptoms and lung function indices among participants. 
However, the study was only able to investigate relative differences in symptom prevalence 
between the exposed groups since the study did not include a non-exposed or external 
group. The results indicate an association between smoking habits and respiratory 
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symptoms, as well as an association between cement dust exposure and respiratory 
symptoms. 
 
The study concluded that coughing, sneezing, wheezing, recurring blocked nose, chest 
tightness, phlegm, chest pain and breathlessness was significantly prevalent among 
participants from both companies. 
4.4.1 Spirometry Results 
There was a difference in the mean value that was observed in both companies for this 
measure. It was also observed that this difference in the mean values of FVC declined with 
subsequent increases in the number of cigarettes smoked per day and the number of years 
that an individual has been smoking.  It was observed in this study that FEV1/FVC% had a 
reverse relationship with smoking cigarettes. However, gender, residential area where 
participants lived, age and level of education were not significantly associated with having 
any of the respiratory clinical symptoms addressed in the study. 
 
The workers that had abnormal spirometric results were referred for further tests and 
management, such as chest x-rays and bronchodilator tests. Employers were also notified 
that such workers had to do follow-up spirometric tests in 6 months’ time to determine any 
changes or progress. Employers were asked to contact the researcher should they need 
more information concerning the recommendations. 
 
One of the studies conducted in the United Kingdom in 2004 suggested that smoking may 
lead to clinically recognised chronic obstructive pulmonary disease (COPD) in 15–20% of  
people who smoke (Willemse et al., 2004). COPD is clinically characterised  by chronic 
respiratory symptoms such as coughing and sputum production, airflow limitation (according 
to the European Respiratory Society (ERS)), a forced expiratory volume in one second 
(FEV1)/vital capacity (VC) ratio of 88% of the predicted value in males and 89% of the 
predicted value in females, as well as an accelerated decline in FEV1 (Willemse et al., 2004). 
Smoking is the most important risk factor for developing COPD, and smoking cessation is 
the only effective treatment for slowing down the accelerated decline in FEV1. Pathological 
changes in the airways of COPD patients were shown to be increased with respect to the 
number and size of glands, inflammation, fibrosis and destruction of alveolar attachments 
(Willemse et al., 2004). 
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The results of this study showed that there were 12 workers who displayed abnormalities 
on spirometric interpretation in Company 2, and only 4 workers in Company 1. In Company 
1, 2 workers presented with mild restriction, 1 worker with moderate obstruction and another 
worker with mild obstruction. The workers who showed abnormal results in Company 1 
were working in the packing plant, where the final cement product is packed and prepared 
for dispatch or delivery. Company 2 had more people who presented with abnormal 
spirometric results that suggested restrictive, obstructive or restrictive-obstructive 
spirometry. Most of these workers were concrete mixer truck drivers who are also involved 
in the production process and the cleaning of trucks after delivery. 
 
Restrictive spirometry arises from diseases that reduce the lung size or increase lung 
stiffness. There is however no obstruction to the airflow, for instance pulmonary fibrosis, 
neuromuscular disease and abnormalities of the chest (OCSA Spirometry Manual, 2013). 
Obstructive spirometry is associated with the symptoms that produce ventilatory disorder 
and reduce the rate of airflow into and out of the lungs. The following diseases are common 
with obstructive spirometry: Asthma, COPD, chronic bronchitis, emphysema, 
Bronchiectasis, Cystic Fibrosis and localised airway obstruction. Obstructive-restrictive 
spirometry arises from a disease process that causes features of both an obstructive and 
restrictive defect, such as cystic fibrosis, which can cause excess mucus production and 
changes in lung tissue (OCSA Spiro metric manual, 2013). 
 
The next chapter discusses challenges, limitations and recommendations developed from 
this study for best practice and management of chronic respiratory symptoms among 
workers exposed to cement dust. 
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CHAPTER 5 
CHALLENGES, LIMITATIONS, RECOMMENDATIONS AND CONCLUSION 
 
In this chapter, challenges that were encountered during the study will be highlighted, as 
well as the limitations of the study, recommendations and finally, the conclusion of the study. 
 
5.1 Challenges 
 The study was completed later than scheduled because one of the cement 
companies selected to take part in the study withdrew participation because they 
were merging with another cement manufacturing industry. 
 The selected cement companies were situated at a distance from one another, thus 
this entailed a lot of travelling. 
 The research was conducted at the participants’ place of employment, so we had to 
wait until they were free (e.g. during lunch breaks and after work) in order for them 
to participate in this study. A majority of participants were employed in the transport 
department, and we therefore had to wait for them to come back from their daily 
deliveries before we could gather data from them. 
 The equipment that was used for this study was borrowed from an Occupational 
Health company, therefore we had to conduct the study on days when there were 
few or no patients booked for tests. 
 The researcher started a new job during the course of the study, so getting time off 
work to conduct the study was a bit challenging. 
 
5.2  Limitations of the study 
 The sample size for this study was small, i.e. 31 participants from Company 1 and 
50 participants from Company 2. The small sample size was also due to budget 
constraints. 
 The cross-sectional nature of this study affected its ability to establish the temporality 
of the symptoms and exposure to cement dust.  
 The health worker effect might have affected the study results since only current 
workers in the cement industry were studied. Workers who had developed 
respiratory symptoms might have left their jobs or changed industries, thus 
underestimating the effect that cement dust exposure might have  on individuals. 
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5.3 Recommendations and conclusion 
5.3.1  Recommendations  
This study revealed that participants from Company 2 do not use respiratory protection gear 
as frequently as they are supposed to. It is therefore recommended that training on the use 
of personal protective equipment, such as respiratory protection gear (dust masks), should 
be carried out. Employers should provide workers with P-, N- or R-95 type respirators to 
minimise the inhalation of dust. Workers should also eat and drink in dust-free areas to 
avoid ingesting cement dust. 
This study revealed that there is a higher prevalence of chronic respiratory symptoms 
among smokers. It is therefore recommended that smoking cessation be encouraged for all 
workers. Smoking cessation will improve respiratory symptoms and prevent accelerated 
decline in lung function. It is recommended that both companies add chest x-rays to their 
medical surveillance, and blood samples and measurements of chemical exposure among 
workers should be conducted annually.  
It is also recommended that engineering control measures, such as High Efficiency 
Particulate Air (HEPA) vacuums, be used to clean up dust instead of dry sweeping. This 
reduces silica exposure during the chipping, drilling and sawing of concrete materials.  
These can also be substituted with the use of other engineering controls, such as wet 
methods and local exhaust ventilation, to reduce dust. Workers should be encouraged to 
use respiratory protection devices during their working hours. Furthermore, blood tests 
need to be introduced to investigate what chemicals workers are exposed to – these can 
be useful in detecting health problems at an early stage. 
The Occupational Safety and Health Administration (OSHA) in the United States (2004) has 
developed very good rules that govern occupational spaces. For South African cement 
industries to be aligned with international best practice standards, it is recommended that 
the following be instituted: 
 Tasks should be performed indoors or in enclosed spaces equipped with an exhaust 
ventilation system to minimize the accumulation of visible airborne dust. 
 Wet methods should be applied, with water at flow rates sufficient to minimize the 
release of visible dust which usually affects the respiratory system. 
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 Where the employer does not implement engineering controls, alternative exposure 
controls should be used, such as the introduction of medical surveillance to 
determine the dangers of exposure. The employer must also ensure that no 
employee is exposed to an airborne concentration of respirable crystalline silica in 
excess of 50 μg/m3, calculated as an 8-hour time-weighted average (TWA). This is 
the acceptable exposure limit (OSHA, 2004). 
  The employer must assess the exposure of each employee who is, or may 
reasonably be expected to be, exposed to respirable crystalline silica at or above the 
action level by means of scheduled medical surveillance monitoring.  
 
 
5.3.2 Conclusion 
In conclusion, emphysema, Asthma, Pneumonia, bronchitis and sinusitis were more 
common among Company 2 employees. Lung disease (Tuberculosis) was detected in one 
person from Company 2. One worker reported emphysema in Company 2. Coughing, 
sneezing, wheezing, recurring blocked nose, bouts of coughing, chest tightness, phlegm, 
chest pain and breathlessness were significantly prevalent in both companies. FVC, FEV1 
and FEV1/FVC% were higher in non-smokers in each age group. The participants who 
were smokers at the time of data collection were more likely to experience respiratory 
symptoms. BMI, age, level of education, area of residence and gender were not significantly 
associated with the spirometric values. The cross-sectional nature and small sample size 
of the current study affects its generalisability, therefore a longitudinal study with a larger 
sample size is recommended. 
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RESEARCH STUDY INFORMATION LETTER 
16 March 2018 
Good Day 
My name is Asanda Mkulisi, I WOULD LIKE TO INVITE YOU TO PARTICIPATE in a 
research study on the Prevalence of Chronic Respiratory Diseases Among Workers Exposed to 
Cement Dust.  
Before you decide on whether or not to participate, I would like to explain to you why the research 
is being done and what participation will entail. I will go through the information letter with you 
and answer any questions you have. This should take about 10 to 20 minutes. The study is part of 
a research project being completed as a requirement for a Master’s Degree in Public Health through 
the University of Johannesburg. 
THE PURPOSE OF THIS STUDY is to see how prevalent chronic respiratory diseases are among 
workers who are exposed to cement dust. 
Below, I have compiled a set of questions and answers that I believe will assist you in understanding 
the relevant details of participation in this research study. Please read these. If you have any further 
questions, I will be happy to answer them for you. 
DO I HAVE TO TAKE PART? No, you do not have to. It is up to you to decide whether or not to 
participate in the study. I will describe the study and go through this information sheet. If you agree 
to take part, I will then ask you to sign a consent form.  
WHAT EXACTLY WILL I BE EXPECTED TO DO IF I AGREE TO PARTICIPATE? Your 
participation will involve completing a respiratory questionnaire, blood pressure measurement, 
height, weight, as well as lung function test. 
WHAT WILL HAPPEN IF I WANT TO WITHDRAW FROM THE STUDY? If you decide to 
participate, you are free to withdraw your consent at any time without giving a reason and without 
any consequences. If you wish to withdraw your consent, you should inform me as soon as possible. 
IF I CHOOSE TO PARTICIPATE, WILL THERE BE ANY EXPENSES FOR ME OR 
PAYMENT DUE TO ME? You will not bear any expenses and you will not be paid to participate 
in the study. 
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RISKS INVOLVED IN PARTICIPATION: You may feel a bit of discomfort in your chest or 
dizziness after doing the lung function test. The procedure for this will be explained as clearly as 
possible to prevent any discomfort, and your blood pressure will be taken prior to the procedure. 
BENEFITS INVOLVED IN PARTICIPATION: This study will help you in identifying any 
health effects on your respiratory system, and therefore allow you to seek  medical advice as early 
as possible if needed. Otherwise, taking part in this study will motivate you to keep healthy and to 
adhere to your company’s PPE standards. 
 
WILL MY PARTICIPATION IN THIS STUDY BE KEPT CONFIDENTIAL? Yes. Names on 
the questionnaire/data sheet will be removed once analysis starts. All data and back-ups thereof will 
be kept in password-protected folders and/or locked away as applicable. Any other person wishing 
to work with your anonymized information as part of the research process (e.g. an independent data 
coder) will be required to sign a confidentiality agreement before being allowed to do so. 
 
  OR 
 
WILL MY TAKING PART IN THIS STUDY BE ANONYMOUS? Yes. Anonymous means that 
your personal details will not be recorded anywhere by me. As a result, it will not be possible for me 
or anyone else to identify your responses once these have been submitted. 
WHAT WILL HAPPEN TO THE RESULTS OF THE RESEARCH STUDY? The results will 
be written out in the form of a research report that will be assessed. In some cases, the results may 
also be published in a scientific journal. In either case, you will not be identifiable in any documents, 
reports or publications. You will be given access to the study results if you would like to see them, 
by contacting me.  
WHO IS ORGANISING AND FUNDING THE STUDY?  The study is being organized by me, 
under the guidance of my research supervisor at the Department of Environmental Health, University 
of Johannesburg. This study has not received any funding yet. 
WHO HAS REVIEWED AND APPROVED THIS STUDY? Before this study was allowed to 
commence, it was reviewed in order to protect your interests. This review was done firstly by the 
Department of Environmental Science, and then secondly by the Faculty of Health Sciences 
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Research Ethics Committee at the University of Johannesburg. In both cases, the study was 
approved. 
WHAT IF THERE IS A PROBLEM? If you have any concerns or complaints about this research 
study, its procedures or risks and benefits, you should ask me. You should contact me at any time if 
you feel you have any concerns about being part of this study. My contact details are:  
Asanda Mkulisi 
0718932005 / 0823048025 
asandamkulisi@gmail.com 
You may also contact my research supervisor: 
Ms Shalin Bidassey-Manilal 
shalinb@uj.ac.za 
If you feel that any questions or complaints regarding your participation in this study have not been 
dealt with adequately, you may contact the Chairperson of the Faculty of Health Sciences Research 
Ethics Committee at the University of Johannesburg: 
Prof. Christopher Stein 
Tel: 011 559-6564 
Email: cstein@uj.ac.za 
FURTHER INFORMATION AND CONTACT DETAILS: Should you wish to have more 
specific information about this research project;  have any questions, concerns or complaints about 
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this research study, its procedures, risks and benefits; you should communicate with me using any 
of the contact details given above. 
 
Researcher: 
 
Asanda Mkulisi 
 
 
 
 
 
 
 
 
Annexure B (Research consent form) 
 
                                              DEPARTMENT OF ENVIRONMENTAL HEALTH 
     RESEARCH CONSENT FORM 
Prevalence of Chronic Respiratory Symptoms Among Workers Exposed to Cement Dust in Gauteng 
Province  
Please initial each box below: 
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                   I confirm that I have read and understand the information letter  for the above study. I 
have had the opportunity to consider the information, ask questions and have had these answered 
satisfactorily. 
 
                    I understand that my participation is voluntary and that I am free to withdraw from this 
study at any time without giving any reason and without any consequences to me. 
 
      I agree to take part in the above study. 
 
____________________       ________________________ ________________ 
Name of Participant   Signature of Participant       Date 
 
____________________      ______________________ ________________ 
Name of Researcher       Signature of Researcher  Date
Annexure C (Research questionnaire) 
UNIVERSITY OF JOHANNESBURG - RESPIRATORY SYSTEM QUESTIONNAIRE 
Section A:  
1. Demographics - Please complete the form with a black pen
For office use only 
Patient no: 
Company no: Date: 
Age: Years Department: 
Job description: Gender: Female-1 Male-
2 
Area where you stay Suburb (1) Township (2) Work history 
(Years) 
Blood Pressure: mmHg Weight (kg): Height (cm): 
2. Ethnicity
Black 1 
White 2 
Coloured 3 
Indian or Asian 4 
3. Your highest educational qualification
Grade 11 or lower (std 9 or lower) 1 
Grade 12 (Matric or std 10) 2 
Post-Matric Diploma or certificate 3 
Baccalaureate Degree(s) 4 
Post-Graduate Degree(s) 5 
 
 
 
Section B: Respiratory questionnaire  
1. Have you ever worked in a mine, quarry, foundry, pottery, cotton, hemp mill? Yes/No 
If yes, please give details of where have you worked before? 
 _____________________________________________________________________ 
2. Do you believe that your chest has suffered as a result of any previous employment? Yes / No 
3. Do you or have you ever had any of the following? (Do not include common cold, sore throat 
or flu) 
Symptoms Yes (Y)                         No (N) 
Recurring blocked or running nose   
Bouts of coughing   
Chest tightness   
Wheezing   
Phlegm   
Chest pain   
Sneezing/stuffy nose   
Fatigue/tiredness   
Rapid breathing   
Recurring soreness or watering of your eyes   
Breathlessness   
Any other persistent or history of chest problem   
 
4.  Have you had any of the following tests done regarding the respiratory system? 
Medical tests YES (tick) NO (tick) 
X-ray   
Blood tests    
Seen medical doctor   
Other medical tests   
 
5.  Regarding your symptoms: 
 
 
 
 Frequency 
How often 
Frequency 
How long 
What triggers the symptoms? Are you 
taking 
medicati
on? 
Do 
sympto
ms 
restrict 
any 
activitie
s? 
Sympto
ms 
D
a
i 
l
y 
W
e
e
k 
l 
y 
Mo 
n 
t 
h 
l 
y 
S 
e 
c 
o 
n 
d 
s 
M 
i 
n 
u 
t 
e 
s 
H 
o 
u 
r 
s 
 
 
 
 
 
 
Work 
enviro
nment 
(Ceme
nt) 
Exer
cise 
 
Stres
s 
Not 
kno
wn 
Y 
e 
s 
N 
o 
Y 
e 
s 
N 
o 
Wheezin
g 
              
Coughin
g 
              
Breathle
ssness 
              
Tight 
chest 
              
Phlegm               
Blocked
/running 
nose 
              
Chest 
pain 
Stuffy 
nose 
Sneezin
g 
Fatigue 
Rapid 
breathin
g 
6. Do you currently smoke?  Yes/ No.
If yes, how many cigarettes per day on average? _______and how long have you been smoking? 
____________months/years. Please specify. 
7. What kind of respiratory protection gear do you use and how often do you change it?
Type of respiratory protection 
gear 
YES (tick) How often is it changed? 
Respirator 
Mask 
1 Have you lost any time from work because you were suffering from any respiratory disease?  
Yes/ No 
Please give details: ___________________________________________________________ 
9. Have you had any illness or operation affecting your chest?
Previous illnesses YES (tick) NO (tick) 
Emphysema 
Asthma 
Pneumonia 
Bronchitis 
Sinusitis 
Lung Disease (Tuberculosis) 
ADDITIONAL COMMENTS OR OBSERVATIONS 
I hereby declare that all answers to the above questions are correctly recorded, and that they are 
complete and true. 
Signature of the Participant: ______        Date: ____________________   
Annexure D1 (Request letter to conduct the study - Company 1) 
Unit 128 
33 Fever Tree Street 
Fleurhofdale Complex 
Fleurhof (Gauteng) 
16 March 2018 
The General Manager 
Afrisam Cement Manufacturer 
Main Reef Road 
Vogelstruisfontein 
Roodepoort (Gauteng) 
REQUEST FOR APPROVAL TO CONDUCT RESEARCH STUDY 
I am a Master’s student at the University of Johannesburg (UJ), under the Department of 
Environmental Health, undertaking research on the “Prevalence of Chronic Respiratory Symptoms 
Among Workers Exposed to Cement Dust in Gauteng Province”. I am conducting this research in 
order to fulfil a Master’s Degree in Public Health. The University of Johannesburg’s Research 
Committee Board requires approval from an employer before I can be granted approval on my 
proposed research topic. 
My studies in Public Health refer to the science and art of preventing diseases, prolonging life, and 
promoting health through the organized efforts and informed choices of society, organizations, 
public and private communities, and individuals. This research will centre around one of your 
facility in Roodepoort, and the results will be shared with you prior to submission to UJ. The 
research will be completed within a period of 30 calendar days. All information provided will be 
treated strictly as confidential and purely for academic purposes. 
For ease of reference, I attach hereto a full proposal submitted to the Department of Environmental 
Health and an information letter submitted to UJ. 
 I am looking forward to your favourable response. 
Yours sincerely 
Asanda Mkulisi 
Approved by: ____________________________________Date:__________________________ 
Annexure D2 (Request letter to conduct the study – Company 2) 
Unit 128  
33 Fever Tree Street 
Fleurhofdale Complex 
Fleurhof (Gauteng) 
16 March 2018 
The General Manager 
Onetime Ready-mix Concrete 
2 Booysens Station, Road 
Johannesburg (Gauteng) 
REQUEST FOR APPROVAL TO CONDUCT RESEARCH STUDY 
I am a Master’s student at the University of Johannesburg (UJ), under the Department of 
Environmental Health, undertaking research on the “Prevalence of Chronic Respiratory Symptoms 
among Workers Exposed to Cement Dust in Gauteng Province”. I am conducting this research in 
order to fulfil a Master’s Degree in Public Health. The University of Johannesburg’s Research 
Committee Board requires approval from an employer before I can be granted approval on my 
proposed research topic. 
My studies in Public Health refer to the science and art of preventing diseases, prolonging life, and 
promoting health through the organized efforts and informed choices of society, organizations, 
public and private communities, and individuals. This research will centre around one of your 
facility in Booysens, and the results will be shared with you prior to submission to UJ. The research 
will be completed within a period of 30 calendar days. All information provided will be treated 
strictly as confidential and purely for academic purposes. 
For ease of reference, I attach hereto a full proposal submitted to the Department of Environmental 
Health and an information letter submitted to UJ. 
 I am looking forward to your favourable response. 
Yours sincerely 
Asanda Mkulisi 
Approved by: ____________________________Date: _______________________________ 
Annexure E (Letter from Statkon) 
Annexure F (Higher Degrees Committee final approval letter) 
Annexure G (Research Ethics Committee final approval letter) 
Annexure H (Certificate of editing) 
Annexure I (Calibration certificates) 
 
 
 
 






